Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sora Neuroscience develops and clinically validates advanced resting-state fMRI analysis tools to assist in the diagnosis and treatment planning of neurological conditions such as brain tumors and epilepsy. Their technology integrates with existing clinical workflows but has not yet received FDA authorization. Validation testing and commercialization efforts are ongoing in partnership with Prism Clinical Imaging and Washington University in St. Louis.
No published clinical trial results or commercial product launches as of June 2025.
Pipeline breadth: Estimated at one main platform/software suite under development for multiple indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sora Neuroscience.